Add to a list

Inactive Instrument

Zomedica Corp. Stock Toronto S.E.

ZOM

CA98980M1095

Healthcare Facilities & Services

OTC Markets Traded

Last Transcript : Zomedica Corp.

Zomedica Corp., Q2 2026 Earnings Call, Aug 28, 2026

08-28

More transcripts

Analysts' recommendations : Zomedica Corp.

23-01-06	Dawson James Starts Zomedica Pharmaceuticals at Buy With $6 Price Target	MT
20-11-16	Zomedica : HC Wainwright Adjusts Zomedica Pharmaceuticals' Price Target to $0.30 From $0.50, Keeps at Buy	MT

More recommendations

Press Releases : Zomedica Corp.

09-09	Zomedica Announces "Fourth Friday at Four" Webinar on September 25, 2026: Inside Zomedica’s Marketing Engine: How Demand Becomes Revenue	AQ
08-13	Zomedica Announces Strategic Collaboration with Boehringer Ingelheim Animal Health Canada Inc. to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform	AQ
08-11	Zomedica Announces "Fourth Friday at Four" Webinar on August 28, 2026: Zomedica International: Building a Global Platform for Veterinary Innovation	AQ
08-05	Zomedica Announces Record Second Quarter Revenue of $9.5 Million, Up 37% Year-Over-Year, Net Loss Reduced 49%, with $44.1 Million in Liquidity	AQ
08-04	Zomedica Launches the PulseVet Acoustic Muffler(TM) Accessory for PulseVet(R) Shock Wave System	AQ

More press releases

Managers and Directors : Zomedica Corp.

Manager	Title	Age	Since
Larry Heaton CEO	Chief Executive Officer	69	2021-10-31
Michael Zuehlke DFI	Director of Finance/CFO	-	2025-04-24
Evan St. Peter CTO	Chief Tech/Sci/R&D Officer	-	2017-12-31

Director	Title	Age	Since
Rodney Williams BRD	Director/Board Member	65	2016-04-26
Jeffrey Rowe CHM	Chairman	70	2019-12-01
Johnny Powers BRD	Director/Board Member	63	2019-08-15

More insiders

Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice economics. Its Diagnostics segment consists of TRUFORMA, VETGuardian, and TRUVIEW products. Its Therapeutic Devices segment consists of Assisi Loop and PulseVet products. Its TRUFORMA platform comprises point-of-care diagnostic products for disease states in dogs, cats and horses, providing assays for use at the point-of-care that provide reference lab accuracy. Its TRUVIEW platform consists of the TRUVIEW digital cystoscopy instrument providing microscopic images and related pathology services which enable practitioners to receive a pathologist interpretation of the images. The Assisi Loop platform includes a series of products that use targeted pulsed electromagnetic field therapy.

Employees

141

Sector

Healthcare Facilities & Services

More about the company

Market Cap	81.51M 70.23M 66.5M 60.27M 113M 7.79B 114M 790M 304M 3.96B 306M 299M 12.52B	P/E 2024	-2.5x	P/E 2025	-1.22x
Enterprise Value	30.44M 26.22M 24.83M 22.51M 42.22M 2.91B 42.44M 295M 113M 1.48B 114M 112M 4.67B	EV / Sales 2024	1,761,223x	EV / Sales 2025	1,518,510x
Free-Float	97.25%	Yield 2024 *	-	Yield 2025	-

08-28	Zomedica Corp., Q2 2026 Earnings Call, Aug 28, 2026
08-05	Zomedica Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-24	Zomedica Corp. - Special Call
06-26	Zomedica Corp. - Special Call
06-10	Zomedica Corp. - Shareholder/Analyst Call
05-29	Zomedica Corp., Q1 2026 Earnings Call, May 29, 2026
05-06	Zomedica Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-24	Zomedica Corp. - Special Call
03-27	Zomedica Corp. - Special Call
03-16	Zomedica Corp. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-27	Zomedica Corp. - Special Call
02-26	Zomedica Expands Distribution of TRUVIEW Digital Microscopy Platform Through National Agreement with Moichor	CI
01-23	Zomedica Corp. - Special Call

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ZOMEDICA CORP.	-6.56%	-8.06%	-	-	81.51M
CVS GROUP PLC	+0.39%	-1.60%	+6.15%	-13.09%	1.2B
WOLVES HAND CO., LTD.	0.00%	+1.36%	+97.90%	-	88.21M
JAPAN ANIMAL REFERRAL MEDICAL CENTER CO., LTD.	-1.50%	-2.77%	+8.74%	+172.75%	82.72M
ZOMEDICA CORP.	-0.86%	-2.00%	-8.57%	-53.21%	81.51M
Average	-1.71%	-1.26%	+26.05%	+35.49%	362.77M
Weighted average by Cap.	-0.17%	-1.51%	+11.05%	-4.21%

	2024	2025
Net sales	27.28 23.51 22.26 20.18 37.85 2.61K 38.04 264.38 101.66 1.33K 102.47 100.22 4.19K	32.03 27.6 26.13 23.68 44.43 3.06K 44.66 310.35 119.34 1.56K 120.29 117.65 4.92K
Net income	-46.98M -40.48M -38.33M -34.74M -65.18M -4.49B -65.51M -455M -175M -2.28B -176M -173M -7.22B	-81.86M -70.53M -66.78M -60.53M -114M -7.82B -114M -793M -305M -3.98B -307M -301M -12.57B
Net Debt	-69.54M -59.91M -56.73M -51.42M -96.47M -6.64B -96.96M -674M -259M -3.38B -261M -255M -10.68B	-51.07M -44M -41.67M -37.77M -70.85M -4.88B -71.21M -495M -190M -2.48B -192M -188M -7.84B

Zomedica Corp. Stock Toronto S.E.

Stocks

ZOM

CA98980M1095

Healthcare Facilities & Services

Valuation : Zomedica Corp.

Latest news : Zomedica Corp.

Last Transcript : Zomedica Corp.

Analysts' recommendations : Zomedica Corp.

Press Releases : Zomedica Corp.

Quotes and Performance

Managers and Directors : Zomedica Corp.

Veterinary Services

Financials

Company Profile